6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays

被引:40
作者
Costi, R
Di Santo, R
Artico, M
Roux, A
Ragno, R
Massa, S
Tramontano, E
La Colla, M
Loddo, R
Marongiu, ME
Pani, A
La Colla, P
机构
[1] Univ Roma La Sapienza, Dipartimento Studi Farmaceut, Fdn Cenci Bolognetti, Inst Pasteur, I-00185 Rome, Italy
[2] Univ Siena, Dipartimento Farm Chim Tecnol, I-53100 Siena, Italy
[3] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Sostanze Biologicament, I-00185 Rome, Italy
[4] Univ Cagliari, Sez Microbiol, Dipartimento Biol Sperimentale, I-09042 Cagliari, Italy
关键词
diketoacids; aryldioxohexenoic acids; pyrrole derivatives; anti-HIV-1-IN agents; QSAR studies;
D O I
10.1016/j.bmcl.2004.01.037
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 6-aryl-2,4-dioxo-5-hexenoic acids, were synthesized and tested against HIV-1 in cell-based assays and against recombinant HIV-1 integrase (rIN) in enzyme assays. Compound 8a showed potent antiretroviral activity (EC50 = 1.5 muM) and significant inhibition against rIN (strand transfer: IC50 = 7.9 muM; 3'-processing: IC50 = 7.0 muM). A preliminary molecular modeling study was carried out to compare the spatial conformation of 8a with those of L-731,988 (4) and 5CITEP (7) in the IN core. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1745 / 1749
页数:5
相关论文
共 27 条
[1]   Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: Synthesis, biological evaluation, and molecular modeling [J].
Artico, M ;
Di Santo, R ;
Costi, R ;
Novellino, E ;
Greco, G ;
Massa, S ;
Tramontano, E ;
Marongiu, ME ;
De Montis, A ;
La Colla, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) :3948-3960
[2]   Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance [J].
Barreca, ML ;
Lee, KW ;
Chimirri, A ;
Briggs, JM .
BIOPHYSICAL JOURNAL, 2003, 84 (03) :1450-1463
[3]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1977, 80 (02) :319-324
[4]   PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES [J].
BERNSTEIN, FC ;
KOETZLE, TF ;
WILLIAMS, GJB ;
MEYER, EF ;
BRICE, MD ;
RODGERS, JR ;
KENNARD, O ;
SHIMANOUCHI, T ;
TASUMI, M .
JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) :535-542
[5]   Combination therapy for HIV: the effect on inpatient activity, morbidity and mortality of a cohort of patients [J].
Brettle, RP ;
Wilson, A ;
Povey, S ;
Morris, S ;
Morgan, R ;
Leen, CLS ;
Hutchinson, S ;
Lewis, S ;
Gore, S .
INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (02) :80-87
[6]   Developing a dynamic pharmacophore model for HIV-1 integrase [J].
Carlson, HA ;
Masukawa, KM ;
Rubins, K ;
Bushman, FD ;
Jorgensen, WL ;
Lins, RD ;
Briggs, JM ;
McCammon, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) :2100-2114
[7]   TOWARD IMPROVED ANTI-HIV CHEMOTHERAPY - THERAPEUTIC STRATEGIES FOR INTERVENTION WITH HIV-INFECTIONS [J].
DECLERCQ, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) :2491-2517
[8]   Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design [J].
Goldgur, Y ;
Craigie, R ;
Cohen, GH ;
Fujiwara, T ;
Yoshinaga, T ;
Fujishita, T ;
Sugimoto, H ;
Endo, T ;
Murai, H ;
Davies, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13040-13043
[9]   Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells [J].
Hazuda, DJ ;
Felock, P ;
Witmer, M ;
Wolfe, A ;
Stillmock, K ;
Grobler, JA ;
Espeseth, A ;
Gabryelski, L ;
Schleif, W ;
Blau, C ;
Miller, MD .
SCIENCE, 2000, 287 (5453) :646-650
[10]  
KAWASUJI T, 2001, Patent No. 0117968